New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Lonza Adds South East/Mid-Atlantic Account Manager

Lonza has announced the addition of Brandon Babers to its Life Science Ingredients-Nutrition group, as South East/Mid-Atlantic Regional Account Manager.

Mr. Babers is responsible for the maintenance and development of business at assigned accounts in the region. He will provide superior customer service though the establishment and maintenance of customer contact, while helping identify customer needs and responding by aligning Lonza technologies to help meet those needs. He will also implement sales strategies and provide support to marketing efforts to help achieve business team objectives.

“Brandon brings a proven track record of strategic account successes to this new position, and we are confident he will build on his knowledge base and experience to enhance Lonza’s nutrition ingredient portfolio,” said Thomas Brancato, Head of North America Sales and Marketing, Lonza. “Brandon’s appointment to this position is reflective of Lonza’s continuous practice of placing top quality personnel in locations that will help us continually develop and maintain relationships with key customers.”

Located in Oldsmar, Fl, Babers holds a Masters Degree in Sports Fitness and Sports Management from the United StatesSportsAcademy in Daphne, Al. He comes to Lonza from Bluebonnet Nutritional Corporation where he most recently held the position of Account Executive.

About Lonza

Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SIX Swiss Exchange. In 2009, Lonza had sales of CHF 2.69 billion. Further information can be found at

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.